Navigation Links
Footrot vaccine closer than ever
Date:7/1/2008

Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep.

The trials have been made possible with funding of $663,000 from Australian Wool Innovation (AWI)

The trials over three years are taking place at Monash University's Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics and the University of Sydney.

Chief investigator Professor Julian Rood said it was an exciting development for his team of researchers.

"The trials are the culmination of 8 years of collaborative work on the pathogenic bacterium which causes footrot, Dichelobacter nodosus. We have determined the bacterium's complete DNA sequence, which was then analysed to identify proteins that are potentially exposed on the surface of the causative bacterium and therefore more likely to elicit an immune response," Professor Rood said.

"The approach, called reverse vaccinology, identified 90 proteins in the footrot bacterium that are potential antigens for a new cross-protective vaccine. This funding will allow us to pinpoint those proteins that will target the disease in a vaccine application," Professor Rood said.

"Our Centre's approach has made significant inroads in the development of a novel vaccine for footrot. The trialling process involves treating sheep with purified surface expressed proteins to assess whether they produce an immune response. The AWI funding means the development of a marketable vaccine is likely to happen a lot sooner. Ideally, this could be within a decade."

Australian Wool Innovation's Program Manager of Animal Health, Productivity and Welfare, Dr Johann Schrder said footrot has long been the bane of Australian woolgrowers and prime lamb producers.

"While many improvements have been made over the years in its control, and we have a very good understanding of measures to limit its impact on production, th
'/>"/>

Contact: Samantha Blair
samantha.blair@adm.monash.edu.au
61-399-034-841
Monash University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Possible hepatitis C vaccine
2. Study by Pittsburgh researchers identifies possible vaccine target for chlamydia
3. New nanoparticle vaccine is more effective but less expensive
4. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
5. Influenza vaccine causes weaker immune response for children of rural Gabon than in semi-urban areas
6. An Alzheimers vaccine?
7. Penn researchers find monkeys able to fend off AIDS-like symptoms with enhanced HIV vaccine
8. CWRU School of Medicine has evidence vaccine against malaria will reduce disease
9. HIV isolate from Kenya provides clues for vaccine design
10. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
11. Vaccine for Ebola virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...w phase 2 data published today in The Lancet sho...trates activity in nonsense-mutation cystic fibros... results in statistically significant improvements... nonsense-mutation CF. The study was conducted at...lem, Israel and sponsored by PTC Therapeutics (PTC...
(Date:8/20/2008)...reated a tiny motorized ,positioning device that ...,developed for applications that include biologica...rd drives. , The device, called a monolithic com...or" that precisely moves or senses movement and ,...ironments for probing ,biological molecules, said...
(Date:8/20/2008)...e of a simple saltwater creature could help resear...n in humans and other species. , A study publish...he genetic code of Trichoplax , a simple saltwate...ld, even in the common household aquarium. , "We... that are also found in other animals - our genome...
(Date:8/20/2008)...controls numerous biological processes including c... is frequently lost or mutated; in fact, alteratio...human cancer that PTEN has become one of the most ...ow, a study led by researchers at Beth Israel Deac...School provides important new insights into PTEN r...
Breaking Biology News(10 mins):PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet 2PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet 3New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3Genome of saltwater creature could aid understanding of gene grouping 2New insights into the regulation of PTEN tumor suppression function 2LifeNet Health Saves 303 Lives and Restores Health to 265 967 Patients in 2007 3423 1LifeNet Health Saves 303 Lives and Restores Health to 265 967 Patients in 2007 3423 2Shire plc 3A Correction Re Website 3421 1Shire plc 3A Correction Re Website 3421 2InfoLogix Inc to Present at the Growth 26 Investor Conference in Fort Lauderdale FL 12338 1InfoLogix Inc to Present at the Growth 26 Investor Conference in Fort Lauderdale FL 12338 2InfoLogix Inc to Present at the Growth 26 Investor Conference in Fort Lauderdale FL 12338 3 Ingen Technologies Registers Oxyview 28R 29 in Taiwan 12333 1 Ingen Technologies Registers Oxyview 28R 29 in Taiwan 12333 2 Ingen Technologies Registers Oxyview 28R 29 in Taiwan 12333 3
... question for so many human interactions and perso...larger role than nurture when it comes to family r.... , Researchers from the University of Texas at Au...n, D.C., used data on 674 families, each with a sa...at made up the relationships and individual person...
...mors release fatty acids that interfere with the c...trategies that reduce the amount of fatty acids su...er therapeutics. The details of these findings app... Research, an American Society for Biochemistry an...ti-cancer therapy rely on what is known as immunot...
...by Professor Ian Day and colleagues at the Univers...on healthcare in the future. , One of two gene mut... and his team in the Human Genetics Division of th...fully applied to search for rare genetic mutations...ed meltMADGE, which combines thermal ramp electrop...
...lating cell volume says Dutch researcher Bas Tomas...ater by the plasma membrane of animal and human ce...ance between water uptake and secretion by the cel...by adjusting the salt concentrations in and around... not known. Bas Tomassen has identified a number o...
Other Biology News:Environment, not genes, key in family relationships 2Researchers discover new tumor defense system 2New gene scanning technology marks a major advance in disease research 2Water management in cells 2
(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
...y to pick up a pizza the other night. I ran into ...rbis, the massive digital image library. Doug is...g product for digital pictures. , ,If, like me, yo...red on your mobile phone the moment for sharing ha...package provides everything you need to create a t...
...ug Association today approved GE Healthcare,s Lu...ed to help doctors detect, diagnose and monitor tr...y low bone mass and increased risk of fracture, mo...The system also enables clinicians to simultaneous...ibution. , ,In addition, GE,s iDXA is capable of ...
...l clip of 16 percent the past two years, Wisconsin...e,s historically known for beer, brats, and milk, ...sconsin," released today at the State Capitol in M...hat,s growing that fast?" she asked. Davy is the e...r Biomedical Research & Education , a non-profit g...
...e agencies received the Center for Digital Governm...in recognition of their innovative use of Web site...operations and interactions. , ,The Center for ...ational research and advisory institute on informa...te and local government. , ,The following projects...
Other Biology Technology:ZoomAlbum operates virtually 2ZoomAlbum operates virtually 3Bioscience beats beer 2Wisconsin state agencies commended for digital innovations 2
CREB-2 (H-290)
Anti-Dynamin Monoclonal Antibody Description: 100 g Research Focus: neuroscience Storage: -20C Shipping Temperature: 4C
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9
Gap junction protein, beta 2, 26kDa (connexin 26) Antigen: Peptide
Biology Products: